v3.22.2.2
FAIR VALUE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK FACTORS - Narrative (Details)
$ in Thousands
12 Months Ended
Aug. 31, 2022
CAD ($)
Dec. 21, 2021
CAD ($)
Aug. 31, 2021
CAD ($)
Aug. 31, 2020
CAD ($)
Disclosure of fair value measurement of equity [line items]        
Liabilities $ 69,049   $ 74,212  
Maximum exposure to credit risk 171,799   235,949  
Cash 68,515   55,365 $ 24,600
Working capital 166,338   234,349  
Contractual capital expenditures $ 15,797      
Change in benchmark interest rates 1.00%      
Laurentian | Weighted average cost of capital, measurement input        
Disclosure of fair value measurement of equity [line items]        
Percentage of reasonably possible increase in unobservable input, liabilities 1.00%      
Increase in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, after tax, liabilities $ 55      
Percentage of reasonably possible decrease in unobservable input, liabilities 1.00%      
Long-term borrowings        
Disclosure of fair value measurement of equity [line items]        
Fair value of long-term debt $ 235   310  
Contingent consideration | Edibles and Infusion Corporation        
Disclosure of fair value measurement of equity [line items]        
Liabilities 7,000   $ 9,038  
Contingent consideration | Laurentian        
Disclosure of fair value measurement of equity [line items]        
Liabilities $ 2,913 $ 6,996    
Minimum | Edibles and Infusion Corporation | Probability of achieving milestones        
Disclosure of fair value measurement of equity [line items]        
Significant unobservable input, liabilities 0   0.10  
Maximum | Edibles and Infusion Corporation | Probability of achieving milestones        
Disclosure of fair value measurement of equity [line items]        
Significant unobservable input, liabilities 1   0.80